Fludrocortisone Therapy in Renal Transplant Recipients with Persistent Hyperkalemia
Hyperkalemia after kidney transplantation is a common electrolyte disturbance and the risk factors are multifactorial. Pharmacotherapeutic agents for chronic management of hyperkalemia in kidney transplant patients may be relatively contraindicated or provide suboptimal efficacy. Fludrocortisone, an...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2012-01-01
|
| Series: | Case Reports in Transplantation |
| Online Access: | http://dx.doi.org/10.1155/2012/586859 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849685780133314560 |
|---|---|
| author | K. Marfo D. Glicklich |
| author_facet | K. Marfo D. Glicklich |
| author_sort | K. Marfo |
| collection | DOAJ |
| description | Hyperkalemia after kidney transplantation is a common electrolyte disturbance and the risk factors are multifactorial. Pharmacotherapeutic agents for chronic management of hyperkalemia in kidney transplant patients may be relatively contraindicated or provide suboptimal efficacy. Fludrocortisone, an endogenous mineralocorticoid mimics the actions of aldosterone, hence hyperkalemia reversal. We describe three- case series of persistent hyperkalemia with demonstrated benefit from fludrocortisone therapy. Our three renal transplant recipients with multiple emergency room visits for elevated serum potassium levels despite treatment with diuretics, sodium bicarbonate, and sodium polystyrene sulfonate responded well to fludrocortisones therapy. Upon fludrocortisone initiation and maintenance therapy, all three patients experienced a decline in serum potassium levels to normal reference range. |
| format | Article |
| id | doaj-art-c71726c415f64deb8fa6fbe4bfd92dfb |
| institution | DOAJ |
| issn | 2090-6943 2090-6951 |
| language | English |
| publishDate | 2012-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Transplantation |
| spelling | doaj-art-c71726c415f64deb8fa6fbe4bfd92dfb2025-08-20T03:22:58ZengWileyCase Reports in Transplantation2090-69432090-69512012-01-01201210.1155/2012/586859586859Fludrocortisone Therapy in Renal Transplant Recipients with Persistent HyperkalemiaK. Marfo0D. Glicklich1Department of Pharmacy & Abdominal Organ Transplantation, Montefiore Medical Center, The University Hospital of Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USADepartment of Medicine and Transplant Nephrology, Montefiore Medical Center, Bronx, NY 10467, USAHyperkalemia after kidney transplantation is a common electrolyte disturbance and the risk factors are multifactorial. Pharmacotherapeutic agents for chronic management of hyperkalemia in kidney transplant patients may be relatively contraindicated or provide suboptimal efficacy. Fludrocortisone, an endogenous mineralocorticoid mimics the actions of aldosterone, hence hyperkalemia reversal. We describe three- case series of persistent hyperkalemia with demonstrated benefit from fludrocortisone therapy. Our three renal transplant recipients with multiple emergency room visits for elevated serum potassium levels despite treatment with diuretics, sodium bicarbonate, and sodium polystyrene sulfonate responded well to fludrocortisones therapy. Upon fludrocortisone initiation and maintenance therapy, all three patients experienced a decline in serum potassium levels to normal reference range.http://dx.doi.org/10.1155/2012/586859 |
| spellingShingle | K. Marfo D. Glicklich Fludrocortisone Therapy in Renal Transplant Recipients with Persistent Hyperkalemia Case Reports in Transplantation |
| title | Fludrocortisone Therapy in Renal Transplant Recipients with Persistent Hyperkalemia |
| title_full | Fludrocortisone Therapy in Renal Transplant Recipients with Persistent Hyperkalemia |
| title_fullStr | Fludrocortisone Therapy in Renal Transplant Recipients with Persistent Hyperkalemia |
| title_full_unstemmed | Fludrocortisone Therapy in Renal Transplant Recipients with Persistent Hyperkalemia |
| title_short | Fludrocortisone Therapy in Renal Transplant Recipients with Persistent Hyperkalemia |
| title_sort | fludrocortisone therapy in renal transplant recipients with persistent hyperkalemia |
| url | http://dx.doi.org/10.1155/2012/586859 |
| work_keys_str_mv | AT kmarfo fludrocortisonetherapyinrenaltransplantrecipientswithpersistenthyperkalemia AT dglicklich fludrocortisonetherapyinrenaltransplantrecipientswithpersistenthyperkalemia |